Evidence map›Paper›PMID 32661322›Full record

ReviewNature reviews. Rheumatology2020

Core and adjunctive interventions for osteoarthritis: efficacy and models for implementation.

Jocelyn L Bowden, David J Hunter, Leticia A Deveza, Vicky Duong, Krysia S Dziedzic, Kelli D Allen, Ping-Keung Chan, Jillian P Eyles

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 4 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 4 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. The IL-4/IL-4R/STAT6 signaling axis regulates macrophage efferocytosis in osteoarthritis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  10. Article
  11. Article
  12. Molecular Detection ofDiagnostics (Basel, Switzerland) · 2026
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Osteoarthritis.Nature reviews. Disease primers · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Jocelyn L BowdenInstitute of Bone and Joint Research, The University of Sydney, Kolling Institute, St Leonards, NSW, Australia. jocelyn.bowden@sydney.edu.au.ORCID http://orcid.org/0000-0002-0340-0232
David J HunterInstitute of Bone and Joint Research, The University of Sydney, Kolling Institute, St Leonards, NSW, Australia. david.hunter@sydney.edu.au.ORCID http://orcid.org/0000-0003-3197-752X
Leticia A DevezaInstitute of Bone and Joint Research, The University of Sydney, Kolling Institute, St Leonards, NSW, Australia.
Vicky DuongInstitute of Bone and Joint Research, The University of Sydney, Kolling Institute, St Leonards, NSW, Australia.ORCID http://orcid.org/0000-0002-4450-8194
Krysia S DziedzicSchool of Primary Community and Social Care, Keele University, Keele, UK.
Kelli D AllenThurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, USA.
Ping-Keung ChanDepartment of Orthopaedics and Traumatology, Queen Mary Hospital, Pok Fu Lam, Hong Kong.
Jillian P EylesInstitute of Bone and Joint Research, The University of Sydney, Kolling Institute, St Leonards, NSW, Australia.ORCID http://orcid.org/0000-0002-1625-8490
The University of Sydney · AUKeele University · GBQueen Mary Hospital · CNUniversity of North Carolina at Chapel Hill · US

Funding

Department of Health KMRF-2014-03-002Department of Health RP-PG-0407-10386
6 · The paper itself

Abstract

Osteoarthritis (OA) is a complex musculoskeletal disease and a leading cause of pain and disability worldwide. Hip and knee OA alone are major contributors to global disability, having notable effects on individual well-being, increasing the reliance of individuals on health-care services and contributing to a rise in the socioeconomic burden. Consistent, coordinated and tailored approaches are important for providing appropriate care to all people with OA, but despite the scale of the challenge many individuals are still not offered the safe, best-evidence treatments recommended for OA care. This Review discusses the core priority treatments for OA, including exercise and physical activity, weight-loss, education and support for self-management. Additional physical or psychological evidence-based adjunctive therapies and combined therapies that can be used to tailor individual programmes are also discussed. These options include cognitive behavioural therapy, heat therapy, walking aids and splints, manual therapies and transcutaneous electrical nerve stimulation. International examples of OA treatment options, models of care and resources available are also given. Many challenges still need to be addressed to advance the uptake of these conditions, including further discussion around the risks and costs involved with all treatments.

Indexed as

Combined Modality TherapyDisease ManagementEvidence-Based PracticeExerciseHumansOsteoarthritisPatient Education as TopicWeight Reduction Programs

Identifiers

PMID32661322
OpenAlexW3041157686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.